Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Operating Income: 2020-2025

Historic Operating Income for IDEAYA Biosciences (IDYA) over the last 4 years, with Sep 2025 value amounting to $108.5 million.

  • IDEAYA Biosciences' Operating Income rose 262.13% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$167.5 million, marking a year-over-year increase of 25.47%. This contributed to the annual value of -$327.0 million for FY2024, which is 143.23% down from last year.
  • As of Q3 2025, IDEAYA Biosciences' Operating Income stood at $108.5 million, which was up 175.24% from -$144.1 million recorded in Q4 2024.
  • In the past 5 years, IDEAYA Biosciences' Operating Income ranged from a high of $108.5 million in Q3 2025 and a low of -$144.1 million during Q4 2024.
  • Over the past 3 years, IDEAYA Biosciences' median Operating Income value was -$41.9 million (recorded in 2023), while the average stood at -$39.2 million.
  • In the last 5 years, IDEAYA Biosciences' Operating Income tumbled by 5,179.70% in 2023 and then surged by 262.13% in 2025.
  • Over the past 5 years, IDEAYA Biosciences' Operating Income (Quarterly) stood at -$18.4 million in 2021, then slumped by 43.95% to -$26.4 million in 2022, then crashed by 58.52% to -$41.9 million in 2023, then tumbled by 243.87% to -$144.1 million in 2024, then skyrocketed by 262.13% to $108.5 million in 2025.
  • Its last three reported values are $108.5 million in Q3 2025, -$144.1 million for Q4 2024, and -$66.9 million during Q3 2024.